Management of massive operative blood loss

Minerva Anestesiologica

Volumn 73, Issue 7-8, 2007, Pages 401-415

  Kozek Langenecker, Sibylle ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anesthesia; Blood component transfusion; Hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 7; DESMOPRESSIN; DEXTRAN; FIBRIN GLUE; FIBRINOGEN; FRESH FROZEN PLASMA; GELATIN; GLUCOSE; GLYCINE; HEPARIN; HETASTARCH; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE; SORBITOL; VIRUS VECTOR; VITAMIN K GROUP; VON WILLEBRAND FACTOR;

ALGORITHM; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD VOLUME; BOLUS INJECTION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CRYOPRECIPITATE; CRYSTALLOID; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CONTRAINDICATION; DRUG INDICATION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; HEMATOCRIT; HEMATOMA; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PATIENT MONITORING; PETECHIA; PLASMA TRANSFUSION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PROTHROMBIN TIME; REVIEW; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; VIRAL GENE DELIVERY SYSTEM; VON WILLEBRAND DISEASE; WOUND HEALING IMPAIRMENT;

ALGORITHMS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; PLATELET FUNCTION TESTS;

EID: 34547905714     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2006;53:S40-58.
2. Levy J. Massive transfusion coagulopathy. Semin Hematol 2006;43:S59-S63.
3. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185-93.
4. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.
5. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002;28 Suppl 2:S241-7.
6. Aucar JA, Norman P, Whitten E, Granchi TS, Liscum KR, Wall MJ et al. Intraoperative detection of traumatic coagulopathy using the activated coagulation time. Shock 2003;19:404-7.
7. Gando S, Tedo I, Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med 1992;20:594-600.
8. Ungerstedt JS, Grenander A, Bredbacka S, Blomback M. Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol 2003;15:13-8.
9. Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg 1996;131:923-7; discussion 7-8.
10. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidosis revisited. J Trauma 1997;42:857-61; discussion 61-2.
11. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005;58:475-80; discussion 80-1.
12. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716-20; discussion 20-2.
13. Hewson JR, Neame PB, Kumar N, Ayrton A, Gregor P, Davis C et al. Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med 1985;13:387-91.
14. Murray DJ, Pennell BJ, Weinstein SL, Olson JD. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995;80:336-42.
15. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
16. deJonge E, Levi M, Berends F. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-90.
17. Wilder DM, Reid TJ, Bakaltcheva IB. Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thromb Res 2002;107:255-61.
18. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996;76:412-4.
19. Kretschmer V, Daraktchiev A, Bade S, Karger R, Kratzer MA. Does hemodilution enhance coagulability? Anaesthesiol Intensivmed Notfallmed Schmerzther 2004;39:751-6.
20. Simmons RL, Collins JA, Heisterkamp CA, Mills DE, Andren R, Phillips LL. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg 1969;169:455-82.
21. Leslie SD, Toy PT. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991;96:770-3.
22. Enderson BL, Chen JP, Robinson R, Maull KI. Fibrinolysis in multisystem trauma patients. J Trauma 1991;31:1240-6.
23. Rohrer M, Natale A. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;20:1402-5.
24. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA, The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study, Anesth Analg 2006;102:1280-4.
25. Valeri C, Feingold H, Cassidy G, Ragno G, Khuri S, Altschule M. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987;205:175-81.
26. Pina-Cabral JM, Ribeiro-da-Silva A, Almeida-Dias A. Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine: reversibility accelerated after intra-abdominal rewarming. Thromb Haemost 1985;54:838-41.
27. Yoshihara H, Yamamoto T, Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res 1985;37:503-12.
28. Engstrom M, Schott U, Romner B, Reinstrup P. Acidosis impairs the coagulation: a thromboelastographic study. J Trauma 2006;61:624-8.
29. Quaknine-Orlando B, Samama CM, Riou B, Bonnin P, Guillosson JJ, Beaumont JL et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 1999;90:1454-61.
30. DeLoughery TG. Coagulation defects in trauma patients: etiology; recognition, and therapy. Crit Care Clin 2004;20:13-24.
31. Practice guidelines for perioperative blood transfusion and adjuvant therapies. An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006;105:198-208.
32. Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004;10:155-66.
33. Rodeghiero F, Castaman G. Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001;14:321-35.
34. Lillicrap D, Nair SC, Srivastava A, Rodeghiero F, Pabinger I, Federici AB. Laboratory issues in bleeding disorders. Haemophilia 2006; 12 Suppl 3:68-75.
35. Eberl W, Wendt I, Schroeder H. Preoperative coagulation screening prior to adenoidectomy and tonsillectomy. Klin Padiatr 2005;217:20-4.
36. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.
37. Ciavarella D, Reed R, Counts R, Baron L, Pavlin E, Heimbach D et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67:365-8.
38. Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190:91-9.
39. Yuan S, Ferrell C, Chandler WL. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2006; [Epub ahead of print].
40. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81:360-5.
41. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006;60:S51-8.
42. Erber WN. Massive blood transfusion in the elective surgical setting. Transfus Apher Sci 2002;27:83-92.
43. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenscgr 1948;26:577-83.
44. Di Benedetto P, Baciarello M, Cabetti L, Martucci M, Chiaschi A, Bertini L. Thrombelastography. Present and future perspectives in clinical practice. Minerva Anestesiol 2003;69:5019, 9-15.
45. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90.
46. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10.
47. Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006;60:S12-9.
48. Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Br J Anaesth 2005;95:310-6.
49. Schmied H, Kurz A, Sessler D, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
50. Kettner S, Kozek S, Groeztner J, Gonano C, Schellongowski A, Kucera M et al. Effects of hypothermia on thrombelastography in patients undergoing cardiopulmonary bypass. Br J Anaesth 1998;80:313-7.
51. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-7, table of contents.
52. Shore-Lesserson L. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Semin Cardiothorac Vasc Anesth 2005;9:41-52.
53. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-9.
54. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004;92:178-86.
55. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001;86:575-8.
56. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773-81; discussion 5A-6A.
57. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995;9:168-73.
58. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000;90:1324-30.
59. Kang Y. Coagulation and liver transplantation: current concepts. Liver Transpl Surg 1997;3:465-7.
60. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004;125:69-73.
61. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006;16:31-9.
62. Watson HG. Thromboelastography should be available in every labour ward. Int J Obstet Anesth 2005;14:325-7.
63. Capraro L, Kuitunen A, Salmenpera M, Kekomaki R. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Acta Anaesthesiol Scand 2001;45: 200-6.
64. Fries D, Haas T, Salchner V, Lindner K, Innerhofer P. [Management of coagulation after multiple trauma]. Anaesthesist 2005;54:137-44.
65. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
66. Spivey M, Parr MJ. Therapeutic approaches in trauma-induced coagulopathy. Minerva Anestesiol 2005;71:281-9.
67. Erber WN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006;19:97-112.
68. Pantanowitz L, Kruskall MS, Uhl L. Cryoprecipitate: patterns of use. Am J Clin Pathol 2003;119:874-81.
69. Goerlinger K, Dirkmann D, Kiss G, Dusse F, Hanke A, Arvieux C et al. ROTEM-based management for diagnosis and treatment of acute haemorrhage during liver transplantation. A322. Eur J Anaesthesiol 2006;23:85.
70. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006;20:548-53.
71. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005;95:172-7.
72. Dzik W, Arkin C, Jenkins R, Stump D. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 1988;71:1090-5.
73. Mannucci PM, Federici AB, Sirchia G. Hemostasis testing during massive blood replacement. A study of 172 cases. Vox Sang 1982;42:113-23.
74. Reed RL 2nd, Ciavarella D, Heimbach DM, Baron L, Pavlin E, Counts RB et al. Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study. Ann Surg 1986;203:40-8.
75. Brandsborg S, Sorensen B, Poulsen LH, Ingerslev J. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients. Blood Coagul Fibrinolysis 2006;17:241-9.
76. Sorensen B, Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 2004;41:140-4.
77. Pusateri AE, Park MS. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Crit Care 2005;9 Suppl 5:S15-24.
78. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003;1:551-8.
79. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000;54:260-4; discussion 4-5.
80. Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 1988;28:406-11.
81. Friesen RH, Perryman KM, Weigers KR, Mitchell MB, Friesen RM. A trial of fresh autologous whole blood to treat dilutional coagulopathy following cardiopulmonary bypass in infants. Paediatr Anaesth 2006;16:429-35.
82. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000;90:801-7.
83. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 2004;17:21-7.
84. Tanaka KA, Szlam F, Kelly AB, Vega JD, Levy JH. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets 2004;15:325-32.
85. Rodgers R. Bleeding time tables: a tabular summary of pertinent literature. Semin Thromb Hemost 1990;16:21-38.
86. Escolar G, Cases A, Vinas M, Pino M, Calls J, Cirera I et al. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica 1999;84:614-9.
87. Barrowcliffe TW, Cattaneo M, Podda GM, Bucciarelli P, Lussana F, Lecchi A et al. New approaches for measuring coagulation. Haemophilia 2006;12 Suppl 3:76-81.
88. Wahba A, Sander S, Birnbaum DE. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery? Thorac Cardiovasc Surg 1998;46:228-31.
89. Forestier F, Coiffic A, Mouton C, Ekouevi D, Chene G, Janvier G. Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? Br J Anaesth 2002;89: 715-21.
90. Bauriedel G, Skowasch D, Schneider M, Andrie R, Jabs A, Luderitz B. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. Am Heart J 2003;145:343-8.
91. Wheeler GL, Braden GA, Steinhubl SR, Kereiakes DJ, Kottke-Marchant K, Michelson AD et al. The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy. Am Heart J 2002;143:602-11.
92. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301-9.
93. Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 2005;145:309-15.
94. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-83.
95. Rivard GE, Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005;3: 2039-43.
96. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-6.
97. Hertfelder HJ, Bos M, Weber D, Winkler K, Hanfland P, Preusse CJ. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost 2005;31:426-40.
98. Golanski J, Chlopicki S, Golanski R, Gresner P, Iwaszkiewicz A, Watala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy. Ther Drug Monit 2005;27: 484-90.
99. Fries D, Innerhofer P, Streif W, Schobersberger W, Margreiter J, Antretter H et al. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg 2003;76:1593-7.